Oral Ofloxacin: A Critical Review of the New Drug Application
Ofloxacin is a fluoroquinolone with activity against gram-positive and gram-negative aerobic and facultatively anaerobic bacteria, chlamydiae, and some related organisms, such as mycoplasmas or mycobacteria. It has been administered orally to 3,903 patients described in the New Drug Application (NDA...
Gespeichert in:
Veröffentlicht in: | Clinical infectious diseases 1992-02, Vol.14 (2), p.539-554 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!